Status:
TERMINATED
Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement
Lead Sponsor:
DePuy Orthopaedics
Conditions:
Osteoarthritis
Rheumatoid Arthritis
Eligibility:
All Genders
Up to 75 years
Phase:
NA
Brief Summary
Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty
Detailed Description
Hydroxyapatite (HA) is a bioactive ceramic that resembles the natural inorganic mineral content of bone, and as such is a highly osteoconductive material. The purpose of this study is to compare an HA...
Eligibility Criteria
Inclusion
- Primary total hip replacement
- Patient age less than or equal to 75
- Sufficient bone stock to support prosthesis
Exclusion
- Previous hip replacement
- Significant angular/bony deformity
- Active joint sepsis
- Metal allergy
- Renal transplant
- Psychosocial disease
- Neurological disease/musculoskeletal disease that may affect weight-bearing
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 29 2009
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT00306917
Start Date
November 1 2002
End Date
January 29 2009
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DePuy Orthopaedics
Warsaw, Indiana, United States, 46581